EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Identifying optimal primary prevention interventions for major cardiovascular disease events and all-cause mortality: a systematic review and hierarchical network meta-analysis of RCTs

Olalekan A Uthman iD, Rachel Court iD, Jodie Enderby iD, Chidozie Nduka iD, Lena Al-Khudairy iD, Seun Anjorin iD, Hema Mistry iD, G J Melendez-Torres iD, Sian Taylor-Phillips iD, Aileen Clarke iD

Health Technology Assessment · 2025-07 · 1-65

DOI: 10.3310/rldh7432 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Health Technology Assessment, 2025-07. Verfasst von Olalekan A Uthman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Primary Prevention. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular disease accounts for substantial mortality and healthcare costs worldwide. Numerous interventions exist for primary prevention but lack head-to-head comparisons on long-term impacts.

Objective

To determine the comparative effectiveness of interventions for primary cardiovascular disease prevention through network meta-analysis of randomised trials. Data sources MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, conference abstracts and trial registries from inception to March 2021. Review methods Randomised controlled trials of pharmacologic therapies, nutritional supplements, lifestyle changes, behavioural approaches and health policies with at least 6 months’ follow-up were included. Pairwise and network meta-analyses were conducted for all-cause mortality, cardiovascular disease events, coronary heart disease and cardiovascular disease mortality.

Results

Data from 139 randomised trials, including 1,053,772 participants, proved suitable for quantitative synthesis. Blood pressure-lowering medications (risk ratio 0.82, 95% confidence interval 0.71 to 0.94), tight blood pressure control (risk ratio 0.66, 95% confidence interval 0.46 to 0.96), statins (risk ratio 0.81, 95% confidence interval 0.71 to 0.91) and multifactorial lifestyle interventions (risk ratio 0.75, 95% confidence interval 0.61 to 0.92) reduced composite cardiovascular events and mortality.

Limitations

Residual confounding may exist. Few direct head-to-head comparisons limited differentiation between some specific modalities.

Conclusions

We found evidence that blood pressure treatments, intense blood pressure targets, statins when appropriate and multifactorial lifestyle changes are the most effective strategies for primary prevention of cardiovascular disease, with unclear effects from other interventions. These findings can inform clinical guidelines and health policies prioritising interventions. Funding This research article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 17/148/05.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesPrimary PreventionHumansHydroxymethylglutaryl-CoA Reductase InhibitorsRandomized Controlled Trials as TopicTechnology Assessment, Biomedical

Stichwörter der Autor:innen

CARDIOVASCULAR DISEASENETWORK META-ANALYSISPOLICY-LEVEL INTERVENTIONSSIMULATION MODELSSTRUCTURAL INTERVENTIONSSYSTEMATIC REVIEW

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.
  • Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
  • University Hospitals Coventry and Warwickshire, Coventry, UK.
  • Peninsula Technology Assessment Group (PenTAG), College of Medicine and Health, University of Exeter, Exeter, UK.

ORCID-Profile: Olalekan A Uthman, Rachel Court, Jodie Enderby, Chidozie Nduka, Lena Al-Khudairy, Seun Anjorin, Hema Mistry, G J Melendez-Torres, Sian Taylor-Phillips, Aileen Clarke

Förderung

  • Health Technology Assessment programme

Zitieren

APA

Uthman, O. A., Court, R., Enderby, J., Nduka, C., Al-Khudairy, L., Anjorin, S., Mistry, H., Melendez-Torres, G. J., Taylor-Phillips, S., & Clarke, A. (2025). Identifying optimal primary prevention interventions for major cardiovascular disease events and all-cause mortality: a systematic review and hierarchical network meta-analysis of RCTs. Health Technology Assessment, 1-65. https://doi.org/10.3310/rldh7432

Vancouver

Uthman OA, Court R, Enderby J, Nduka C, Al-Khudairy L, Anjorin S, et al. Identifying optimal primary prevention interventions for major cardiovascular disease events and all-cause mortality: a systematic review and hierarchical network meta-analysis of RCTs. Health Technology Assessment. 2025:1-65. doi:10.3310/rldh7432

BibTeX
@article{Uthman2025,
  author = {Uthman, Olalekan A and Court, Rachel and Enderby, Jodie and Nduka, Chidozie and Al-Khudairy, Lena and Anjorin, Seun and Mistry, Hema and Melendez-Torres, G J and Taylor-Phillips, Sian and Clarke, Aileen},
  title = {Identifying optimal primary prevention interventions for major cardiovascular disease events and all-cause mortality: a systematic review and hierarchical network meta-analysis of RCTs},
  journal = {Health Technology Assessment},
  year = {2025},
  pages = {1--65},
  doi = {10.3310/rldh7432}
}
Kostenlos starten →